Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 570 clinical trials
A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

first-line chemotherapy regimen using Rituximab+Cyclophosphamide+Doxorubicin +Vincristine+BonisoneR-CHOPsignificantly increases the remission rate and disease-free survival of patients with DLBCL, but

  • 0 views
  • 22 Jan, 2021
  • 1 location
Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation

This is a guideline for the treatment of graft failure after hematopoietic stem cell transplant (HSCT). This regimen, consisting of cyclophosphamide and fludarabine with low dose total body

  • 0 views
  • 25 Jan, 2021
  • 1 location
Study of Refractory and/or Relapsing TAkayasu aRTeritis

stabilization of vascular abnormalities (Shelhamer et al, 1985; Maksimowicz-McKinnon et al, 2007). Although second-line agents (methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide) may result in

stenosis
vasculitis
remission
tumor necrosis factor
tocilizumab
  • 1 views
  • 22 Jan, 2021
  • 1 location
Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy

The purpose of this study is to predict the ovarian reserve, especially premature ovarian insufficient (POI), in young breast cancer patients during chemotherapy treatment using ultrasensitive anti-Mllerian hormone (AMH) detection method.

  • 0 views
  • 28 Feb, 2021
  • 1 location
International PPB/DICER1 Registry

Pleuropulmonary blastoma (PPB) is a rare malignant neoplasm of the lung presenting in early childhood. Type I PPB is a purely cystic lesion, Type II is a partially cystic, partially solid tumor, Type III is a completely solid tumor. Treatment of children with PPB is at the discretion of the …

solid tumor
initial diagnosis
cancer
sarcoma
  • 37 views
  • 23 Jan, 2021
  • 1 location
EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)

The aim of the study is to assess the effectiveness of various post-transplant treatment management approaches on clinical and immune biological responses after Autologous Hematopoietic Stem Cell transplantation (AHSCT) for Systemic Sclerosis (SSc) as currently performed by the different treatment protocols used in routine clinical practice across Europe in various …

treatment regimen
progressive systemic sclerosis
  • 0 views
  • 23 Jan, 2021
Epidemiological Clinical and Etiological Features of SUSAC's Syndrome

SUSAC's Syndrome (SS) is characterized by the clinical triad of encephalopathy, hearing loss, and retinal artery branch occlusions. Since the first description of SS in 1979, hundreds of patients with SS, mostly young women, have been reported. However, comprehensive epidemiological, clinical and etiological features of SS have never been specifically …

audiogram
sensorineural hearing loss
hard of hearing
  • 67 views
  • 21 Jan, 2021
  • 1 location
The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma

Annually some 450 patients are diagnosed with Diffuse Large B-cell Lymphoma (DLBCL), in Denmark. The majority of these patients are cured with immunochemotherapy, but up to 30 % will relapse, pointing to the need for targeted surveillance and follow-up strategy. However, this strategy is constantly under debate illustrated by the …

  • 0 views
  • 18 Feb, 2021
  • 1 location
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer

Neoadjuvant (preoperative) chemotherapy is an interesting research tool which allows investigators to test new drugs and/or new schedules with a validated surrogate endpoint, pCR. It also represents an ideal model to evaluate the relationships between treatments and tumor biomarkers. Recent publications have shown that new molecular classifications of breast cancer …

BRCA1
HER2
carcinoma
taxane
erbb2
  • 0 views
  • 25 Jan, 2021
  • 1 location
The Influence of Extracorporeal Photopheresis on Skin Sclerosis

Extracorporeal photopheresis (ECP), also known as extracorporeal photoimmunotherapy or photochemotherapy, is a leukapheresis-based therapy that has been in clinical use for over three decades after receiving FDA approval in 1988. Extracorporeal photopheresis was initially used for the treatment of T-cell lymphoma. Since its introduction, indications for initiating ECP were continuously …

  • 0 views
  • 21 Feb, 2021